Breaking news

OpenAI Unveils Enhanced Image Generator API for Developers

In a significant leap for AI capabilities, OpenAI has opened up its improved image generation technology to developers through its API. This move signifies a bold step forward in integrating AI-generated visuals into diverse applications and services.

Launched initially in ChatGPT, the new image generator gained rapid popularity due to its ability to create realistic, Studio Ghibli-style illustrations and imaginative AI action figures. Its widespread use led to an exceptional surge in ChatGPT sign-ups, with over 130 million users producing a staggering 700 million images in just one week.

The technology behind this innovation, known as ‘gpt-image-1’, is a versatile multimodal model capable of crafting images across various styles, guided by custom parameters, and embedding text with precision. Developers leveraging this API can generate multiple images simultaneously while adjusting the quality and speed of image production.

OpenAI ensures that its image generation adheres to robust safety protocols, employing guardrails to prevent non-compliant content creation. Developers have the choice to customize content moderation, balancing between standard and low-filter options, the latter allowing a broader range of content categories.

Moreover, all AI-generated images carry C2PA metadata, allowing supported platforms to identify them as AI-created, integral in maintaining authenticity and transparency.

Cost-effectiveness remains crucial, with pricing set at $5 per million input tokens for text and $10 per million input tokens for images, scaling to $40 per million output tokens. This equates to approximately 2-19 cents per generated image, depending on quality.

Many notable companies, including Adobe and Canva, are experimenting with integrating this groundbreaking technology. Platforms like Figma have even added features that empower users to edit and create images directly through GPT-Image-1.

As AI technology continually evolves, this development not only marks a milestone for OpenAI but also underscores the potential of AI in enhancing creativity and efficiency across various industries. For a deeper dive, discover how Cyprus’s tech ventures are also leaping forward.

Reid Hoffman Leaves Microsoft Board To Focus On Manus AI

Former Microsoft board member Reid Hoffman has stepped down from the company’s board, marking a return to startup building and investment activities. Hoffman joined Microsoft’s board following the company’s $26.2 billion acquisition of LinkedIn in 2016.

Strategic Investment And Board Leadership

During his time on the board, Hoffman was involved in a period of significant investment in artificial intelligence, including Microsoft’s first $1 billion investment in OpenAI in 2019. As an early investor in OpenAI, Hoffman also served on the organisation’s board before stepping down in 2023 to avoid potential conflicts of interest.

Acqui-Hire Deals And AI Synergies

Hoffman’s board tenure coincided with significant strategic moves, including Microsoft’s $650 million acqui-hire deal involving his AI startup, Inflection AI. This arrangement, which saw Microsoft adding Inflection co-founder Mustafa Suleyman to its ranks, highlights the increasingly blurred lines between corporate reinvention and startup innovation in the tech landscape.

Return to Founder Mode With Manus AI

In a recent conversation on his “Possible” podcast with Microsoft CEO Satya Nadella, Hoffman revealed his excitement to return to “founder mode” with his latest venture, Manus. This AI-driven drug discovery startup has already raised over $50 million through early seed rounds, marking it as a promising player in the competitive field of AI in healthcare.

Leadership Under Visionary Guidance

Hoffman serves as co-founder and chair of Manus AI. Day-to-day leadership is led by Dr. Siddhartha Mukherjee, a physician, biologist and Pulitzer Prize-winning author of The Emperor of All Maladies: A Biography of Cancer. The company is focused on applying artificial intelligence to chemistry and drug discovery, including research related to cancer treatment. Hoffman’s departure from Microsoft’s board comes as he increases his focus on new ventures in artificial intelligence and healthcare.

Aretilaw firm
Uol
The Future Forbes Realty Global Properties
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter